Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by DONOOWon Oct 18, 2021 5:30pm
97 Views
Post# 34020095

RE:RE:RE:Reduvo

RE:RE:RE:Reduvo

when i ask my self what should i say ,i dont find better than what the buddy said !!

Iscfa :
I think the co. is pushing the idea that Tetra's vape product is going to gain a share of the broad pain market beyond what Tetra's product is indicated for with terminal cancer. The clinical study is rigged because pot smoke through the lungs is always going to have faster onset than opioids that are digested through the gut. But physicians will not prescibe pot smoking for general pain due to the harmful effects. Also, there are many co.s working on the delivery of cannabis molecules via topical, sublingual, etc.    


quote=ClausWalter01]For the amateur pumper crowd here are a few thoughts that I dummied down for you:

Scientifically there is nothing remotely exciting to say to the medical world they already don't know about pain and pot because that ship sailed years ago.   Many, many docs gave medical cannabis prescriptions to patients who wanted to try the stuff and 100% all came back to their pharma pain meds and synthetic opiates. Pot is a poor product in general and tetra hasn’t improved it at all.   Yes, people choose to smoke pot on their journey through terminal cancer because the pain is brutal.  This is not new and shame on Guy for playing this story up thinking he has some magical regulatory know-how nobody else has.  He always talks like tetra has some top-secret metabolite understanding about the stuff.  The cherry on top was this microbiome in pot plant soil IP.   Its laughable at best. 

Commercially, there is no insurer that will be generous on its reimbursement for terminal stage pain cannabis because opiates work so well, and pot is shaky at best.  You are competing with Black Market or better yet the Quasi-Regulated Markets, medical or otherwise.  Guy knows full well he will bring a product to market (because health Canada is chalked full of amateur scientist that want so badly to justify the paper pushing) for which there is no "true" market because its already saturated with recreational and illegal cannabis stuff or untouchable reservation products.  So pumpers ought to ask him to make some projections about future sales.  COGS are impossible to justify when pot is pretty much legal and so accessible.  Imagine that, a $600 smokable GMP strain provided by Tetra in someone else’s device for your terminal cancer pain.....again laughable and commercially a no go.  

Futility is what phama call his poor clinical efforts with your hard-earned cash.  

If I am Hexo or others I love that you idiot shareholders paid millions to confirm that pot is an option for terminally ill people.  Duh.  Tetra will boost sales for the sector just not its shareholders.  

So looking forward to the tetra-defenders to lynch me on this one and use some of your sophisticated stickhandling to prove me right again and again.  


bring it. 

 


[/quote]

<< Previous
Bullboard Posts
Next >>